Which industry partner should I collaborate with? A scientists’ journey to implementing an innovative technology

2022-06-06T21:59:54+00:00June 3rd, 2022|Comments Off on Which industry partner should I collaborate with? A scientists’ journey to implementing an innovative technology

Scalable Electroporation of Adult Keratinocytes with Multiplexed CRISPR Ribonucleoproteins for the Development of Novel Cell Therapeutics

2022-05-11T17:40:23+00:00May 10th, 2022|Comments Off on Scalable Electroporation of Adult Keratinocytes with Multiplexed CRISPR Ribonucleoproteins for the Development of Novel Cell Therapeutics

Conditional Deletion of Large DNA Fragment in iPSCs by ssODN-Mediated Insertion of LoxP Sites without Antibiotic Selection

2022-03-07T16:47:17+00:00February 5th, 2022|Comments Off on Conditional Deletion of Large DNA Fragment in iPSCs by ssODN-Mediated Insertion of LoxP Sites without Antibiotic Selection

Highly Efficient Homozygous Correction of the DYSF Gene in Miyoshi Myopathy Patient iPSCs by ssODN-Mediated Knockin

2022-03-07T16:48:11+00:00February 5th, 2022|Comments Off on Highly Efficient Homozygous Correction of the DYSF Gene in Miyoshi Myopathy Patient iPSCs by ssODN-Mediated Knockin

Efficient ssODN-Mediated Targeting by Avoiding Cellular Inhibitory RNAs through Precomplexed CRISPR-Cas9/sgRNA Ribonucleoprotein

2021-11-03T20:31:34+00:00November 3rd, 2021|Comments Off on Efficient ssODN-Mediated Targeting by Avoiding Cellular Inhibitory RNAs through Precomplexed CRISPR-Cas9/sgRNA Ribonucleoprotein

Preclinical evaluation for engraftment of CD34+ cells gene-edited at the sickle cell disease locus in xenograft mouse and non-human primate models

2021-11-03T20:19:50+00:00November 3rd, 2021|Comments Off on Preclinical evaluation for engraftment of CD34+ cells gene-edited at the sickle cell disease locus in xenograft mouse and non-human primate models
Go to Top